California Public Employees Retirement System Reduces Stock Position in Humana Inc. (NYSE:HUM)

California Public Employees Retirement System lessened its position in Humana Inc. (NYSE:HUM) by 56.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 200,352 shares of the insurance provider’s stock after selling 257,299 shares during the period. California Public Employees Retirement System owned 0.17% of Humana worth $50,831,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock valued at $3,254,899,000 after purchasing an additional 1,751,857 shares during the period. State Street Corp grew its position in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after buying an additional 53,272 shares during the last quarter. Pzena Investment Management LLC increased its stake in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after buying an additional 1,103,132 shares during the period. Norges Bank bought a new position in shares of Humana during the fourth quarter valued at approximately $416,202,000. Finally, Boston Partners lifted its stake in Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock worth $279,236,000 after acquiring an additional 893,637 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.0 %

Shares of Humana stock opened at $264.55 on Wednesday. The company has a 50-day simple moving average of $269.37 and a two-hundred day simple moving average of $272.67. The stock has a market capitalization of $31.93 billion, a PE ratio of 26.59, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana’s payout ratio is 35.58%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research reports. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Piper Sandler increased their price target on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Truist Financial lifted their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Finally, Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Eighteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.